A detailed history of Evercore Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 37,266 shares of LLY stock, worth $29.7 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
37,266
Previous 40,486 7.95%
Holding current value
$29.7 Million
Previous $36.7 Million 9.93%
% of portfolio
0.5%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $2.49 Million - $3.09 Million
-3,220 Reduced 7.95%
37,266 $33 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $37,693 - $47,270
-52 Reduced 0.13%
40,486 $36.7 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $3.24 Million - $4.33 Million
-5,469 Reduced 11.89%
40,538 $31.5 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $438,008 - $516,354
-834 Reduced 1.78%
46,007 $26.8 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $325,155 - $448,276
-748 Reduced 1.57%
46,841 $25.2 Million
Q2 2023

Aug 04, 2023

SELL
$350.74 - $468.98 $243,062 - $325,003
-693 Reduced 1.44%
47,589 $22.3 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $362,505 - $425,744
-1,167 Reduced 2.36%
48,282 $16.6 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $38,907 - $45,335
-121 Reduced 0.24%
49,449 $18.1 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $22,236 - $25,340
-75 Reduced 0.15%
49,570 $16 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $455,444 - $534,759
-1,634 Reduced 3.19%
49,645 $16.1 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $311,433 - $387,032
-1,327 Reduced 2.52%
51,279 $14.7 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $404,730 - $502,272
-1,800 Reduced 3.31%
52,606 $14.5 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $412,176 - $507,240
-1,860 Reduced 3.31%
54,406 $12.6 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $513,664 - $664,421
-2,845 Reduced 4.81%
56,266 $12.9 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $401,433 - $519,674
-2,443 Reduced 3.97%
59,111 $11 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $160,465 - $212,334
-1,230 Reduced 1.96%
61,554 $10.4 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $35,092 - $40,591
240 Added 0.38%
62,784 $9.29 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $24,009 - $28,895
-176 Reduced 0.28%
62,544 $10.3 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $973,114 - $1.2 Million
-8,174 Reduced 11.53%
62,720 $8.7 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $49,931 - $61,844
-467 Reduced 0.65%
70,894 $9.32 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $186,882 - $203,280
-1,750 Reduced 2.39%
71,361 $7.98 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $182,360 - $212,860
1,646 Added 2.3%
73,111 $8.1 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $206,146 - $242,649
-1,852 Reduced 2.53%
71,465 $9.27 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $69,682 - $78,065
-658 Reduced 0.89%
73,317 $8.49 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $327,727 - $409,602
-3,817 Reduced 4.91%
73,975 $7.94 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $4.08 Million - $4.68 Million
53,840 Added 224.78%
77,792 $6.64 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $31,168 - $36,792
-420 Reduced 1.72%
23,952 $1.85 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $119,632 - $128,319
-1,460 Reduced 5.65%
24,372 $2.06 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $1.99 Million - $2.21 Million
25,832
25,832 $2.21 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.